The estimated Net Worth of Richard Kraniak is at least $10.9 Milhão dollars as of 5 August 2011. Richard Kraniak owns over 150 units of OptimizeRx Corp stock worth over $10,899,980 and over the last 13 years Richard sold OPRX stock worth over $0.
Richard has made over 1 trades of the OptimizeRx Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Richard bought 150 units of OPRX stock worth $399 on 5 August 2011.
The largest trade Richard's ever made was buying 150 units of OptimizeRx Corp stock on 5 August 2011 worth over $399. On average, Richard trades about 150 units every 0 days since 2011. As of 5 August 2011 Richard still owns at least 1,497,250 units of OptimizeRx Corp stock.
You can see the complete history of Richard Kraniak stock trades at the bottom of the page.
Richard's mailing address filed with the SEC is , , , , .
Over the last 2001 years, insiders at OptimizeRx Corp have traded over $20,012,815 worth of OptimizeRx Corp stock and bought 258,753 units worth $1,128,145 . The most active insiders traders include Investment Company, Inc. Awm, Bradley Louis Radoff, eDavid Harrell. On average, OptimizeRx Corp executives and independent directors trade stock every 32 days with the average trade being worth of $183,485. The most recent stock trade was executed by Patrick D Spangler on 5 June 2024, trading 10,061 units of OPRX stock currently worth $73,244.
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
OptimizeRx Corp executives and other stock owners filed with the SEC include: